Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DaBomb Protein Biotech is a Taiwan-based public biotech company focused on animal health and nutrition rather than human therapeutics. The company develops antibiotic alternatives for livestock using postbiotics, fermented plant proteins, soybean peptides, synbiotic and immune-support products, and related feed solutions. Its business appears centered on commercial animal nutrition and feed-additive products designed to improve immune strength, gut health, and production performance in livestock. DaBomb positions itself as a pioneer in fermentation-derived protein and postbiotic products for the animal health industry, with operations based in Tainan, Taiwan and a listing on the Taipei Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Da Bomb.